BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2432727)

  • 1. Intravenous treatment of autoimmune hemolytic anemia with very high dose gammaglobulin.
    Bussel JB; Cunningham-Rundles C; Abraham C
    Vox Sang; 1986; 51(4):264-9. PubMed ID: 2432727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose intravenous gammaglobulin in Coombs positive hemolytic anemia.
    Mitchell CA; Van der Weyden MB; Firkin BG
    Aust N Z J Med; 1987 Jun; 17(3):290-4. PubMed ID: 2445328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial stabilization preceding enhanced hemolysis in autoimmune hemolytic anemia treated with intravenous gammaglobulin.
    Richmond GW; Ray I; Korenblitt A
    J Pediatr; 1987 Jun; 110(6):917-9. PubMed ID: 2438396
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of intravenous gamma globulin for the treatment of autoimmune neutropenia of childhood and autoimmune hemolytic anemia.
    Hilgartner MW; Bussel J
    Am J Med; 1987 Oct; 83(4A):25-9. PubMed ID: 3118705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful treatment of infantile chronic autoimmune hemolytic anemia with high-dose intravenous gamma globulin].
    Hasegawa K; Todo S; Imashuku S
    Rinsho Ketsueki; 1986 Aug; 27(8):1421-6. PubMed ID: 2432290
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of high-dose intravenous gamma globulins in the treatment of autoimmune hemolytic anemia].
    Bussel A; Jaisson F; Janvier M; Traulle C; Schenmetzler C
    Presse Med; 1983 Nov; 12(41):2628. PubMed ID: 6197710
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients.
    Flores G; Cunningham-Rundles C; Newland AC; Bussel JB
    Am J Hematol; 1993 Dec; 44(4):237-42. PubMed ID: 8237993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous usage of gammaglobulin: humoral immunodeficiency, immune thrombocytopenic purpura, and newer indications.
    Bussel JB; Cunningham-Rundles C
    Cancer Invest; 1985; 3(4):361-6. PubMed ID: 4040795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose intravenous immunoglobulin in the treatment of autoimmune haemolytic anaemia.
    Majer RV; Hyde RD
    Clin Lab Haematol; 1988; 10(4):391-5. PubMed ID: 3250787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternation of two doses of intravenous gammaglobulin in the maintenance treatment of patients with immune thrombocytopenic purpura: more is not always better.
    Bussel JB; Fitzgerald-Pedersen J; Feldman C
    Am J Hematol; 1990 Mar; 33(3):184-8. PubMed ID: 1689103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hemolytic anemia in infancy and successful treatment with high dose intravenous gammaglobulins.
    Donfrancesco A; Miano C; Rosati D
    Haematologica; 1987; 72(3):281-2. PubMed ID: 2442077
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of intravenous gamma globulin in autoimmune-mediated pediatric blood dyscrasias.
    Kurtzberg J; Friedman HS; Chaffee S; Falletta JM; Kinney TR; Kurlander R; Matthews TJ; Schwartz RS
    Am J Med; 1987 Oct; 83(4A):4-9. PubMed ID: 3118707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders.
    Besa EC
    Am J Med; 1988 Apr; 84(4):691-8. PubMed ID: 3400663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of Idiopathic Thrombocytopenic Purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency.
    Ramyar A; Aghamohammadi A; Moazzami K; Rezaei N; Yeganeh M; Cheraghi T; Pouladi N; Heydari G; Abolhassani H; Amirzargar AA; Parvaneh N; Moin M
    Iran J Allergy Asthma Immunol; 2008 Sep; 7(3):169-75. PubMed ID: 18780952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous gamma globulin for thrombocytopenia in children with Evans syndrome.
    Nuss R; Wang W
    Am J Pediatr Hematol Oncol; 1987; 9(2):164-7. PubMed ID: 2438958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: review of the literature.
    Bussel JB; Pham LC
    Vox Sang; 1987; 52(3):206-11. PubMed ID: 2440183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dramatic effects of high-dose intravenous gammaglobulin in each patient with intractable dermatomyositis and polymyositis].
    Morita R; Nakano K; Hirano Y; Izumi T; Hirayama Y; Suzuki H; Shishikura K; Okada N; Osawa M; Fukuyama Y
    No To Hattatsu; 1989 Nov; 21(6):523-8. PubMed ID: 2478176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolysis due to high-dose intravenous gammaglobulin treatment for patients with idiopathic thrombocytopenic purpura.
    Nakamura S; Yoshida T; Ohtake S; Matsuda T
    Acta Haematol; 1986; 76(2-3):115-8. PubMed ID: 2433882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic false-positive serologic tests for syphilis and other serologic abnormalities in autoimmune hemolytic anemia and thrombocytopenic purpura.
    Conley CL; Savarese DM
    Medicine (Baltimore); 1989 Mar; 68(2):67-84. PubMed ID: 2646509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late appearance of thrombotic thrombocytopenic purpura after autoimmune hemolytic anemia and in the course of chronic autoimmune thrombocytopenic purpura: two case reports.
    Krupsky M; Sarel R; Hurwitz N; Resnitzky P
    Acta Haematol; 1991; 85(3):139-42. PubMed ID: 2042447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.